Schnitzler syndrome: Diagnostics and treatment;Schnitzler-syndrom: Diagnostika a léčba

Klinicka Onkologie

Volumn 24, Issue 4, 2011, Pages 271-277

  Szturz, Petr ^a   Adam, Z ^a   Sediva A ^b   Fojtik Z ^a   Corbova D ^c   Neubauer, J ^a   Prasek J ^c   Hajek R ^a   Mayer, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Amyloidosis; Interleukin 1 receptor antagonist protein; Interleukins; Multiple myeloma; Paraproteinemias

Indexed keywords

AMYLOIDOSIS; CANCER CENTER; CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; PATIENT REFERRAL; REVIEW; SCHNITZLER SYNDROME; TREATMENT INDICATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; SCHNITZLER SYNDROME;

EID: 80052199830     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Schnitzler L, Schubert B, Boasson M et al. Urticaire chronique lésions osseuses macroglobulinémie IgM: maladie de Waldenstrom? Bull Soc Fr Dermatol Syph 1974; 81: 363-366.
2. Besada E, Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol 2010; 29(5): 567-571.
3. Lipsker D, Veran Y, Grunenberger F et al. The Schnitzler syndrome, four new cases and review of the literature. Medicine (Baltimore) 2001; 80(1): 37-44. (Pubitemid 32066377)
4. de Koning HD, Bodar EJ, van der Meer JW et al. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007; 37(3): 137-148. (Pubitemid 350151505)
5. Gilson M, Abad S, Larroche C et al. Treatment of Schnitzler's syndrome with anakinra. Clin Exp Rheumatol 2007; 25(6): 931.
6. Loock J, Lamprecht P, Timmann C et al. Genetic predisposition (NLRP3V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome. J Allergy Clin Immunol 2010; 125(2): 500-502.
7. Eiling E, Schröder JO, Gross WL et al. The Schnitzler syndrome: chronic urticaria and monoclonal gammopathy - an autoinflammatory syndrome? J Dtsch Dermatol Ges 2008; 6(8): 626-631.
8. Kluger N, Bessis D, Guillot B. Tocilizumab as a potential treatment in Schnitzler syndrome. Med Hypotheses 2009; 72(4): 479-480.
9. Adam Z, Krejčí M, Pour L et al. Schnitzlerův syndrom - popis čtrnáctiletého průběhu nemoci a přehled informací o této nemoci. Vnitř Lék 2008; 54(12): 1140-1153.
10. Sanmartín O, Febrer I, Botella R et al. Urticarial lesions and monoclonal IgM gammopathy. Schnitzler's syndrome. Arch Dermatol 1994; 130(9): 1193-1198. (Pubitemid 24288482)
11. Kieffer C, Cribier B, Lipsker D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore) 2009; 88(1): 23-31.
12. Berdy SS, Bloch KJ. Schnitzler's syndrome: a broader clinical spectrum. J Allergy Clin Immunol 1991; 87(4): 849-854.
13. Borradori L, Rybojad M, Puissant A et al. Urticarial vasculitis associated with a monoclonal IgM gammopathy: Schnitzler's syndrome. Br J Dermatol 1990; 123(1): 113-118. (Pubitemid 20226523)
14. Janier M, Bonvalet D, Blanc MF et al. Chronic urticaria and macroglobulinemia (Schnitzler's syndrome): report of two cases. J Am Acad Dermatol 1989; 20(2 Pt 1): 206-211. (Pubitemid 19055626)
15. Olsen E, Førre O, Lea T et al. Unique antigenic determinants (idiotypes) used as markers in a patient with macroglobulinemia and urticaria. Similar idiotypes demonstrated in the skin and on peripheral blood lymphocytes. Acta Med Scand 1980; 207(5): 379-384.
16. Lecompte M, Blais G, Bisson G et al. Schnitzler's syndrome. Skeletal Radiol 1998; 27(5): 294-296.
17. De Waele S, Lecouvet FE, Malghem J et al. Schnitzler's syndrome: an unusual cause of bone pain with suggestive imaging features. AJR Am J Roentgenol 2000; 175(5): 1325-1327.
18. Flórez AF, Gallardo-Agromayor E, García-Barredo R et al. Radiological aid to clinical diagnosis of Schnitzler's syndrome: multimodality imaging approach. Clin Rheumatol 2008; 27(1): 107-110.
19. Krejčí IM, Adam Z, Hájek R. Mnohočetný myelom. Klin Onkol 2008; 21 (Suppl 1): 187-189.
20. Pujol RM, Barnadas MA, Brunet S et al. Urticarial dermatosis associated with Waldenström's macroglobulinemia. J Am Acad Dermatol 1989; 20 (5 Pt 1): 855-857. (Pubitemid 19127930)
21. Lipsker D, Cribier B, Maloisel F et al. Chronic urticaria and IgA myeloma. Acta Derm Venereol 1998; 78(5): 395.
22. Karakelides M, Monson KL, Volcheck GW et al. Monoclonal gammopathies and malignancies in patients with chronic urticaria. Int J Dermatol 2006; 45(9): 1032-1038. (Pubitemid 44317114)
23. Ščudla V, Budíková M, Petrová P et al. Analýza sérových hladin vybraných biologických ukazatelů u monoklonální gamapatie nejistého významu a mnohočetného myelomu. Klin Onkol 2010; 23(3): 171-181.
24. Fojtík Z, Adam Z, Krejčí M et al. Diferenciální diagnostika syndromu Schnitzlerové a dalších chorob způsobujících urtiku, kostní bolesti a subfebrilie. In: Rovenský J, Pavelka K, Plank L et al (eds). Vybrané kazuistiky v reumatológii. Bratislava SAP 2009: 81-101.
25. Šedivá A. Poruchy regulace zánétu a periodické horečky Alergie 2006; 8(1): 36-41.
26. Claes K, Bammens B, Delforge M et al. Another devastating complication of the Schnitzler's syndrome: AA amyloidosis. Br J Dermatol 2008; 158(1): 182-184. (Pubitemid 350221902)
27. Martinez-Taboada VM, Fontalba A, Blanco R et al. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 2005; 52(7): 2226-2227. (Pubitemid 40994347)
28. Šedivá A, Poloučková A, Podrazil M et al. Characterization of the B-cell compartment in a patient with Schnitzler syndrome. Scand J Rheumatol 2010; 40(2): 158-160.
29. Lebbe C, Rybojad M, Klein F et al. Schnitzler's syndrome associated with sensorimotor neuropathy. J Am Acad Dermatol 1994; 30(2 Pt 2): 316-318. (Pubitemid 24045495)
30. Eiling E, Möller M, Kreiselmaier I et al. Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol 2007; 57(2): 361-364. (Pubitemid 47048871)
31. Thonhoffer R, Uitz E, Graninger W. Schnitzler's syndrome-exacerbation after anti-TNF treatment. Rheumatology 2007; 46(6): 1041-1042. (Pubitemid 47062523)
32. de Koning HD, Bodar FJ, Simon A et al. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 2006; 65(4): 542-544.
33. Obořilová A, Adam Z. Schnitzler's syndrome. Vnitř Lék 1998; 44(7): 423-427.
34. Stahl N, Radin A, Mellis S. Rilonacept-CAPS and beyond. Ann N Y Acad Sci 2009; 1182: 124-134
35. Church LD, McDermott MF. Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes. Expert Rev Clin Immunol 2010; 6(6): 831-841.